ITM Power's £86.5m Backing Fails to Convince the Market as Execution Doubts Linger

ITM Power secures £46.5m grant and £40m equity from UK government but shares fall 9.67% in a week amid cash burn and analyst downgrades.

The British electrolyser maker has secured a hefty injection of state and institutional support, yet the share price continues to drift lower. A £46.5m grant from the UK energy department, paired with a £40m equity commitment from Great British Energy, was intended to fund the next-generation Chronos production line at ITM Power's Sheffield facility. Chief executive Dennis Schulz called the package a milestone that positions the company at the heart of Britain's hydrogen economy. The market, however, was less impressed: the stock closed the week at €1.22, down 9.67% over seven sessions and 15.53% over the past month.

That decline has erased a significant portion of this year's gains, though the shares still trade 69.18% higher since January. The pullback from the 52-week high of €2.58, struck on 29 May, now stands at 52.52% — a stark reminder of the volatility that has defined the hydrogen sector in recent months. The 14-day relative strength index has fallen to 36.9, drifting into oversold territory, while annualised 30-day volatility has climbed above 100%.

Analyst sentiment has turned more cautious even as the funding news broke. A revised fair value estimate now stands at £1.20 per share, down from £1.31 two weeks earlier. That marks the second consecutive downgrade from the same research house. Berenberg, by contrast, holds a more optimistic 200-pence target, though even that bank acknowledges the wide gap between bullish projections and what the market is pricing in. The divergence reflects deep uncertainty over whether ITM Power can convert its financing and pipeline into sustainable profitability.

The company is still burning cash. For the first half of fiscal 2026, which ends in April, ITM reported a record revenue of £18m and raised its full-year guidance to a range of £40m to £43m — a 35% jump from the prior year. But operating profits remain elusive. Morgan Stanley, among the more upbeat institutional watchers, does not expect a positive operating result before 2028. That timeline helps explain why the stock sits 25.95% below its 50-day moving average of €1.65, a technical signal that normally flags mounting selling pressure.

The Chronos investment is designed to address the capacity constraints that have plagued the company, using manufacturing processes already proven on the Trident line. Yet the market is demanding tangible progress on factory utilisation and order conversion before it rewards the equity. Every delay in project milestones, Berenberg notes, could put current valuation assumptions at risk.

For now, ITM Power remains caught between a favourable policy backdrop and the hard reality of execution risk. The state money is in place, the guidance has been raised, and a handful of analysts still see significant upside. But until the company demonstrates that its expanded production line can translate into steady, profitable revenue, the wide spread between bullish targets and cautious fair-value estimates will keep the shares swinging sharply with each new data point.